Michael Ulz
Stock Analyst at Morgan Stanley
(5)
Main Sectors:
Top Industries:
45 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceutic... | Maintains: Equal-Weight | 405 475 | 453.74 | 4.69% | 12 | Oct 6, 2025 | |
IONS Ionis Pharmaceutical... | Maintains: Overweight | 71 86 | 69 | 24.64% | 6 | Sep 23, 2025 | |
KPTI Karyopharm Therapeut... | Maintains: Outperform | 42 25 | 6.57 | 280.52% | 7 | Aug 12, 2025 | |
SLN Silence Therapeutics | Maintains: Overweight | 45 25 | 5.11 | 389.24% | 12 | May 9, 2025 | |
VKTX Viking Therapeutics | Maintains: Overweight | 105 102 | 31.59 | 222.89% | 3 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 40 20 | 5.63 | 255.24% | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 22 | 2.4 | 816.67% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | 16.16 | 79.46% | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 11 7 | n/a | n/a | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 20 | 2.26 | 784.96% | 4 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 20 5 | n/a | n/a | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 10 | 1.58 | 532.91% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 46 96 | 45.74 | 109.88% | 4 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 48 52 | 12.89 | 303.41% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 110 115 | n/a | n/a | 9 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 53 57 | 72.66 | -21.55% | 3 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 36 27 | 38.82 | -30.45% | 4 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 47 65 | n/a | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 3 7 | 1.39 | 403.6% | 8 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 23 12 | n/a | n/a | 4 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 27 | 12.74 | 111.93% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 37 | n/a | n/a | 9 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 35 40 | n/a | n/a | 4 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 30 20 | 1.67 | 1097.6% | 3 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 45 | 3.23 | 1293.19% | 1 | Feb 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 10 | 0.84 | 1090.48% | 3 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 8 | n/a | n/a | 5 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 3 | 4.79 | -37.37% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 18 30 | 5.75 | 421.74% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 135 90 | n/a | n/a | 3 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 15 7 | n/a | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 25 30 | n/a | n/a | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | n/a | n/a | n/a | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 84 36 | n/a | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 45 | n/a | n/a | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 500 | n/a | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 300 500 | 8.13 | 6050.06% | 2 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | n/a | n/a | 1 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 1 | n/a | n/a | 4 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 4 | n/a | n/a | 3 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 0 | n/a | n/a | 2 | Sep 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 680 544 | n/a | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 85 80 | 30.89 | 158.98% | 2 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 12 15 | 8.4 | 78.57% | 3 | Jul 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 127 182 | n/a | n/a | 2 | Feb 27, 2017 |